{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:50:22Z","timestamp":1787784622619,"version":"build-2784847793"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["20747"],"award-info":[{"award-number":["20747"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["20380"],"award-info":[{"award-number":["20380"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research Biomedical Research Centre"},{"name":"National Institute for Health Research Clinical Research Network"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/rheumatology\/key306","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T15:16:25Z","timestamp":1537283785000},"page":"331-335","source":"Crossref","is-referenced-by-count":32,"title":["Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom"],"prefix":"10.1093","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0377-1575","authenticated-orcid":false,"given":"Lianne","family":"Kearsley-Fleet","sequence":"first","affiliation":[{"name":"Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Sampath","sequence":"additional","affiliation":[{"name":"Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza J","family":"McCann","sequence":"additional","affiliation":[{"name":"Clinical Academic Department of Paediatric Rheumatology, Alder Hey Children\u2019s NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Baildam","sequence":"additional","affiliation":[{"name":"Clinical Academic Department of Paediatric Rheumatology, Alder Hey Children\u2019s NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5400-9911","authenticated-orcid":false,"given":"Michael W","family":"Beresford","sequence":"additional","affiliation":[{"name":"Clinical Academic Department of Paediatric Rheumatology, Alder Hey Children\u2019s NHS Foundation Trust, UK"},{"name":"Institute of Translational Medicine (Child Health), University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Davies","sequence":"additional","affiliation":[{"name":"Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"De Cock","sequence":"additional","affiliation":[{"name":"Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E","family":"Foster","sequence":"additional","affiliation":[{"name":"Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Paediatric Rheumatology, Great North Children\u2019s Hospital, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taunton R","family":"Southwood","sequence":"additional","affiliation":[{"name":"Institute of Child Health, University of Birmingham and Birmingham Children\u2019s Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Thomson","sequence":"additional","affiliation":[{"name":"Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Faculty of Biologic, Medicine and Health, University of Manchester, Manchester, UK"},{"name":"National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-9262","authenticated-orcid":false,"given":"Kimme L","family":"Hyrich","sequence":"additional","affiliation":[{"name":"Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"},{"name":"National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"key":"key\n\t\t\t\t2019012308085226000_key306-B1","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B2","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B3","volume-title":"Clinical Commissioning Policy Statement: Biologic Therapies for the treatment of Juvenile Idiopathic Arthritis (JIA)","author":"NHS England","year":"2015"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B4","author":"European Medicines Agency","year":"2017"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10067-011-1720-7","article-title":"Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis","volume":"30","author":"Alexeeva","year":"2011","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/RHU.0b013e3181ba3c6f","article-title":"Rituximab therapy produced rapid and sustained clinical improvement in a patient with systemic onset juvenile idiopathic arthritis refractory to TNF alpha antagonists","volume":"15","author":"Feito","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.2008.092106","article-title":"Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis","volume":"68","author":"Narvaez","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5152\/eurjrheumatol.2014.140049","article-title":"A successful treatment of juvenile idiopathic arthritis with rituximab: a report of two cases","volume":"1","author":"Berrada","year":"2014","journal-title":"Eur J Rheumatol"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.rbr.2014.12.015","article-title":"Rituximab use in young adults diagnosed with juvenile idiopathic arthritis unresponsive to conventional treatment: report of 6 cases","volume":"55","author":"Sakamoto","year":"2015","journal-title":"Rev Bras Reumatol"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B10","first-page":"45","article-title":"Anti CD20 (rituximab) therapy in refractory pediatric rheumatic diseases","volume":"41","author":"Reis","year":"2016","journal-title":"Acta Reumatol Port"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2011-201117","article-title":"Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis","volume":"72","author":"Isaacs","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B12","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/rheumatology\/kev429","article-title":"Factors associated with choice of biologic among children with juvenile idiopathic arthritis: results from two UK paediatric biologic registers","volume":"55","author":"Kearsley-Fleet","year":"2016","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B13","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B14","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/rheumatology\/ket150","article-title":"Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis","volume":"52","author":"McErlane","year":"2013","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B15","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B16","volume-title":"Stata Statistical Software: Release 13","author":"StataCorp","year":"2013"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B17","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/art.39197","article-title":"Medically significant infections are increased in patients with juvenile idiopathic arthritis treated with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study","volume":"67","author":"Davies","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/rheumatology\/kex304","article-title":"Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis","volume":"57","author":"Silva-Fernandez","year":"2018","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/cc11304","article-title":"Clinical review: serious adverse events associated with the use of rituximab\u2014a critical care perspective","volume":"16","author":"Kasi","year":"2012","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t2019012308085226000_key306-B20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.semarthrit.2016.06.001","article-title":"Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): analysis from the UK Childhood Arthritis Prospective Study (CAPS)","volume":"46","author":"Davies","year":"2016","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/58\/2\/331\/27583804\/key306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T06:52:27Z","timestamp":1571899947000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/58\/2\/331\/5144589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,10,24]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key306","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,10,24]]}}}